Primary Site >> Biliary tract Cancer
Gene >> MT1E
|
|
|---|---|
|
Ref: A phase I study of sorafenib, oxaliplatin and 2 days of high dose capecitabine in advanced pancreatic and biliary tract cancer: a Wisconsin oncology network study. PMID: 23263993 |
Ref: A phase I trial investigating pulsatile erlotinib in combination with gemcitabine and oxaliplatin in advanced biliary tract cancers. PMID: 27853997 |